Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
EGFR-mutated Non-Small Cell Lung Cancer (NSCLC).
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Relapsed/refractory B-cell Acute Lymphoblastic Leukemia (ALL) or CD33-positive Acute Myeloid Leukemia (AML).
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
EGFR-mutated Non-Small Cell Lung Cancer (NSCLC).
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Approved for use in oncology care according to FDA-approved indications.
Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), relapsed or refractory Ph+ CML, gastrointestinal stromal tumors (GIST), and hypereosinophilic syndrome.